Melanoma | Tumor

NFL Star Randy Moss Undergoing Cancer Treatment, Montell Jordan Shares Update and More

December 20th 2024, 4:00pm

Article

From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the cancer space this week.

First Patient Enrolled Receives Kimmtrak in Phase 3 Uveal Melanoma Trial

December 16th 2024, 10:00pm

Article

The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak or observation.

Nemvaleukin Shows Manageable Safety Profile in Advanced Solid Tumors

December 3rd 2024, 8:00pm

Article

In patients with advanced solid tumors, treatment with nemvaleukin with or without Keytruda demonstrated antitumor activity and tolerability.

Addressing Pros and Cons of CAR-T Cell Therapy in Melanoma

November 14th 2024, 4:00pm

Video

The advantages and disadvantages of CAR-T cell therapy should be carefully thought about for patients with melanoma.

TIL Therapy Uses the Body’s Own Cells to Attack Cancer Cells in Melanoma

November 13th 2024, 2:00pm

Video

An expert explained how a patient’s own T cells can be extracted, manufactured and infused back into the body as a treatment option for melanoma.

Opdivo and Yervoy May Improve Survival for Resected Stage 3/4 Melanoma

October 31st 2024, 7:00pm

Article

Patients with resected stage 3 or 4 melanoma treated with immune-oncology agents demonstrated significantly higher cure rates compared to those treated with placebo.

Longer Time Until Recurrence Associated With Better Melanoma Outcomes

October 2nd 2024, 1:00pm

Article

An expert explains study findings that associate a longer time until postsurgical melanoma recurrence with improved progression and survival.

Long-Term Study Data Support Keytruda as Standard of Care for Advanced Melanoma

October 1st 2024, 9:00pm

Article

Keytruda continued to improve survival versus Yervoy in unresectable stage 3 or 4 melanoma in long-term follow-up data.

Oncology Drugs Approved by the FDA in September 2024

October 1st 2024, 3:00pm

Article

Throughout September, the FDA approved drugs for the treatment of diseases including lung cancer, multiple myeloma, thyroid cancer and breast cancer.

Survival Benefit Continues at 10 Years From Opdivo Either Alone or With Yervoy in Advanced Melanoma

September 25th 2024, 1:00pm

Article

Findings from the CheckMate 067 of patients with advanced melanoma include the longest follow-up of a checkpoint inhibitor in any tumor type.